Fixed-Dose Trial in Early Parkinson's Disease (PD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of tavapadon and placebo in participants with early PD.
Epistemonikos ID: 1e23ec801dec9eba05063022b7fd50c4128b5925
First added on: May 06, 2024